Uveitis Treatment Market, By Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), By Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan u

Uveitis Treatment Market, By Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), By Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan uveitis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Uveitis refers to inflammation caused in the uvea of the eye. A uvea is the middle layer of the eye that consists of three components namely iris, cilliary body, and the choroid. Uveitis is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides. However, in many cases the cause of this condition remains unknown. It is also found to be effecting people belonging to the age group of 20–50 years. The condition is classified based on the location of inflammation in the uvea and is categorized in three types including anterior uveitis that causes inflammation in the iris and is the most commonly encountered type.
Restraints of the Global Uveitis Treatment Market
Major factors hampering the growth of the uveitis treatment market during the forecast period constitutes of limited studies on efficacy comparison of treating agents, and challenging manufacturing process.
Key features of the study:
This report provides in-depth analysis of the global uveitis treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global uveitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Allergan, Inc., Novartis AG, Valeant Pharmaceuticals International, Inc., Galapagos, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Inc., AbbVie Inc., Tarsius Pharma, Eyegate Pharmaceuticals, Inc., Alimera Sciences Inc., and pSivida Corp.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Uveitis Treatment Market, By Treatment Type:
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
Global Uveitis Treatment Market, By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan uveitis
Global Uveitis Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Global Uveitis Treatment Market, By Geography:
North America
By Treatment Type
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
By Disease Type
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan uveitis
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
U.S.
Canada
Europe
By Treatment Type
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
By Disease Type
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan uveitis
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Treatment Type
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
By Disease Type
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan uveitis
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Treatment Type
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
By Disease Type
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan uveitis
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Treatment Type
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
By Disease Type
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan uveitis
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
GCC
Israel
Rest of Middle East
Africa
By Treatment Type
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
By Disease Type
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan uveitis
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Allergan, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Novartis AG
Valeant Pharmaceuticals International, Inc.
Galapagos
EyePoint Pharmaceuticals, Inc.
Clearside Biomedical, Inc.
AbbVie Inc.
Tarsius Pharma
Eyegate Pharmaceuticals, Inc.
Alimera Sciences Inc.
pSivida Corp.
“*” marked represents similar segmentation in other categories in the respective section.